New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - rubella vaccine - suspension for injection - active: rubella vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

smithkline and french -

Ireland - English - HPRA (Health Products Regulatory Authority)

smithkline and french -

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - meningococcal polysaccharide vaccine, group a, c, w135 and y - lyophilized powder for injection (sc) - 50 mcg/ 0.5ml

Philippines - English - FDA (Food And Drug Administration)

pfizer, inc. - meningococcal polysaccharide vaccine, group a, c, w135 and y - powder for injection sc

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - neisseria meningitidis group a polysaccharide 50ug;  ; neisseria meningitidis group c polysaccharide 50ug;  ; neisseria meningitidis group w135 polysaccharide 50ug;  ; neisseria meningitidis group y polysaccharide 50ug;   - suspension for injection - 50µg/0.5ml - active: neisseria meningitidis group a polysaccharide 50ug   neisseria meningitidis group c polysaccharide 50ug   neisseria meningitidis group w135 polysaccharide 50ug   neisseria meningitidis group y polysaccharide 50ug   excipient: sucrose trometamol sodium chloride water for injection - mencevax acwy is indicated for active immunisation of adults and children over two years against meningococcal meningitis caused by group a, group c, group w-135 and group y meningococci. the vaccine may also be used for: · subjects who are close contacts of patients with disease caused by meningococci of groups a, c, w-135 and y. · travellers to countries where the disease is epidemic or highly endemic. · controlling epidemics of infection caused by group a, c, w-135, y meningococci in confined communities. mencevax acwy is not recommended for use in infants and children under two years of age, as antigenicity of the vaccine is low in this age group and antibodies persist for shorter duration.

Canada - English - Health Canada

glaxosmithkline inc - meningococcal polysaccharide antigen group a; meningococcal polysaccharide antigen group c; sodium chloride - powder for solution - 2.5mg; 2.5mg; 25ml - meningococcal polysaccharide antigen group a 2.5mg; meningococcal polysaccharide antigen group c 2.5mg; sodium chloride 25ml - vaccines

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - meningococcal polysaccharide - lyophilized powder for injection

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - meningococcal polysaccharide - lyophilized powder for injection

Malta - English - Medicines Authority

smithkline beecham limited 980, great west road, brentford middlesex tw8 9gs, united kingdom - neisseria meningitidis, polysaccharide group, meningococcal polysaccharide, group w - powder and solvent for solution for injection - neisseria meningitidis polysaccharide group c 50 µg meningococcal polysaccharide group w-135 50 µg - vaccines